Clinical Research on Retinal Neovascularization of Diabetic Retinopathy

Not Applicable

Terminated

• Conditions: Retinopathy.; The Mechanism of Retinal Neovascularization of Diabetic

• Registration Number: NCT01229540
• Lead Sponsor: Tianjin Medical University

Brief Summary

Retinal neovascularization of diabetic retinopathy might be associated with genetic risk factors and environmental risk factors.

Detailed Description

Not available

Study Timeline

• Status Verified: 2008-09
• Study First Submitted: 2010-10-26
• Study First Submitted QC: 2010-10-26
• Last Update Submitted: 2010-10-26
• Study First Posted: 2010-10-27
• Last Update Posted: 2010-10-27

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• T2DM was diagnosed according to the World Health Organization Expert Consultation Report 1999 and consisted of one of the following: fasting blood glucose (FBG) ≥7.0 mmol/L (≥126 mg/dL), blood glucose ≥11.1 mmol/L (≥200 mg/dL) 2 hours after an oral glucose tolerance test (OGTT); or a random blood glucose ≥11.1 mmol/L (≥200 mg/dL).
• DR was clinically graded in accordance with the International Clinical Diabetic Retinopathy guidelines based on fundus fluorescence angiography.
• All participants with PDR underwent a comprehensive dilated fundus examination to detect DR by indirect ophthalmoscopy and were diagnosed by fundus fluorescence angiography.

Exclusion Criteria

• Patients were excluded if they had acute complications of diabetes mellitus, type 1 diabetes mellitus, other types of diabetes, serious cardiovascular, hepatic, nephritic or other complications, other serious primary diseases or mental illness.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Tianjin Eye Hospital, Clinical college of Ophthalmology ,Tianjin Medical Univercity; 🇨🇳 Tianjin, Tianjin, China